Oral, Head & Neck Cancer Awareness Week 2026: Precision Matters in Radiotherapy

During Oral, Head & Neck Cancer Awareness Week 2026, the global community highlights the importance of early detection, multidisciplinary care, and advanced treatment strategies. These cancers account for hundreds of thousands of new cases each year, making precise and reliable therapy essential for improving outcomes and preserving quality of life.

In radiotherapy for head & neck indications, millimeter-level accuracy is critical. Sensitive structures such as the spinal cord, salivary glands, optic pathways, and brainstem demand highly controlled dose delivery and consistent patient positioning across every treatment fraction.

The RPS Head was developed to meet these challenges – enabling precise cranial and head & neck positioning in stereotactic and image-guided radiotherapy workflows. By supporting accurate alignment and reproducibility, it helps clinicians deliver treatment safely and confidently.

Technology alone does not treat cancer – but precision engineering empowers those who do.